1245 related articles for article (PubMed ID: 22258781)
21. Comparative risk of early postoperative pulmonary embolism after cemented total knee versus total hip arthroplasty with low-dose warfarin prophylaxis.
Vresilovic EJ; Hozack WJ; Booth RE; Rothman RH
Am J Knee Surg; 1996; 9(1):2-6. PubMed ID: 8835022
[TBL] [Abstract][Full Text] [Related]
22. The Role of Intraoperative Intermittent Pneumatic Compression Devices in Venous Thromboembolism Prophylaxis in Total Hip and Total Knee Arthroplasty.
Tyagi V; Tomaszewski P; Lukasiewicz A; Theriault S; Pelker R
Orthopedics; 2018 Jan; 41(1):e98-e103. PubMed ID: 29156069
[TBL] [Abstract][Full Text] [Related]
23. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review.
Januel JM; Chen G; Ruffieux C; Quan H; Douketis JD; Crowther MA; Colin C; Ghali WA; Burnand B;
JAMA; 2012 Jan; 307(3):294-303. PubMed ID: 22253396
[TBL] [Abstract][Full Text] [Related]
24. Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?
Yokote R; Matsubara M; Hirasawa N; Hagio S; Ishii K; Takata C
J Bone Joint Surg Br; 2011 Feb; 93(2):251-6. PubMed ID: 21282767
[TBL] [Abstract][Full Text] [Related]
25. Inpatient Mortality and Morbidity for Dialysis-Dependent Patients Undergoing Primary Total Hip or Knee Arthroplasty.
Ponnusamy KE; Jain A; Thakkar SC; Sterling RS; Skolasky RL; Khanuja HS
J Bone Joint Surg Am; 2015 Aug; 97(16):1326-32. PubMed ID: 26290083
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty.
Mantilla CB; Horlocker TT; Schroeder DR; Berry DJ; Brown DL
Anesthesiology; 2003 Sep; 99(3):552-60; discussion 5A. PubMed ID: 12960538
[TBL] [Abstract][Full Text] [Related]
27. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Geerts WH; Pineo GF; Heit JA; Bergqvist D; Lassen MR; Colwell CW; Ray JG
Chest; 2004 Sep; 126(3 Suppl):338S-400S. PubMed ID: 15383478
[TBL] [Abstract][Full Text] [Related]
28. Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates.
Hart A; Khalil JA; Carli A; Huk O; Zukor D; Antoniou J
J Bone Joint Surg Am; 2014 Dec; 96(23):1945-51. PubMed ID: 25471908
[TBL] [Abstract][Full Text] [Related]
29. Thromboprophylaxis following hip and knee arthroplasty.
Mirkazemi C; Bereznicki LR; Peterson GM
Intern Med J; 2013 Feb; 43(2):124-9. PubMed ID: 23402484
[TBL] [Abstract][Full Text] [Related]
30. Predictors of perioperative blood loss in total joint arthroplasty.
Park JH; Rasouli MR; Mortazavi SM; Tokarski AT; Maltenfort MG; Parvizi J
J Bone Joint Surg Am; 2013 Oct; 95(19):1777-83. PubMed ID: 24088970
[TBL] [Abstract][Full Text] [Related]
31. The Effectiveness of a Risk Stratification Protocol for Thromboembolism Prophylaxis After Hip and Knee Arthroplasty.
Nam D; Nunley RM; Johnson SR; Keeney JA; Clohisy JC; Barrack RL
J Arthroplasty; 2016 Jun; 31(6):1299-1306. PubMed ID: 26777547
[TBL] [Abstract][Full Text] [Related]
32. Comorbidities and perioperative complications in HIV-positive patients undergoing primary total hip and knee arthroplasty.
Lin CA; Kuo AC; Takemoto S
J Bone Joint Surg Am; 2013 Jun; 95(11):1028-36. PubMed ID: 23780541
[TBL] [Abstract][Full Text] [Related]
33. High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis.
Kerr J; Linkins LA
Thromb Haemost; 2010 Jan; 103(1):123-8. PubMed ID: 20062935
[TBL] [Abstract][Full Text] [Related]
34. Combined (mechanical and pharmacological) modalities for the prevention of venous thromboembolism in joint replacement surgery.
Kakkos SK; Warwick D; Nicolaides AN; Stansby GP; Tsolakis IA
J Bone Joint Surg Br; 2012 Jun; 94(6):729-34. PubMed ID: 22628585
[TBL] [Abstract][Full Text] [Related]
35. Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.
Sharrock NE; Gonzalez Della Valle A; Go G; Lyman S; Salvati EA
Clin Orthop Relat Res; 2008 Mar; 466(3):714-21. PubMed ID: 18264861
[TBL] [Abstract][Full Text] [Related]
36. Multimodal thromboprophylaxis in low-risk patients undergoing lower limb arthroplasty: A retrospective observational cohort analysis of 1400 patients with ultrasound screening.
Harrison-Brown M; Scholes C; Douglas SL; Farah SB; Kerr D; Kohan L
J Orthop Surg (Hong Kong); 2020; 28(2):2309499020926790. PubMed ID: 32484038
[TBL] [Abstract][Full Text] [Related]
37. Changes of D-dimer after total hip arthroplasty in patients with and without intraoperative heparin.
Maezawa K; Nozawa M; Aritomi K; Kubota M; Shitoto K; Kurosawa H
Arch Orthop Trauma Surg; 2008 Jan; 128(1):37-40. PubMed ID: 17522875
[TBL] [Abstract][Full Text] [Related]
38. New oral anticoagulants for thromboprophylaxis after total hip or knee arthroplasty.
Friedman RJ
Orthopedics; 2009 Dec; 32(12 Suppl):79-84. PubMed ID: 20201481
[TBL] [Abstract][Full Text] [Related]
39. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
Asopa V; Cobain W; Martin D; Keene G; Bauze A
ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
[TBL] [Abstract][Full Text] [Related]
40. Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4/heparin antibody formation after orthopedic surgery.
Bito S; Miyata S; Migita K; Nakamura M; Shinohara K; Sato T; Tonai T; Shimizu M; Shibata Y; Kishi K; Kubota C; Nakahara S; Mori T; Ikeda K; Ota S; Minamizaki T; Yamada S; Shiota N; Kamei M; Motokawa S
Blood; 2016 Feb; 127(8):1036-43. PubMed ID: 26659923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
